eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease
Staphylococcus Aureus Infection
Updated: Jan 23, 2009
Introduction
Background
Bacteria of the genus Staphylococcus are gram-positive cocci that are microscopically observed as individual organisms, in pairs, and in irregular, grapelike clusters. The term Staphylococcus is derived from the Greek term staphyle, meaning "a bunch of grapes." Staphylococci are nonmotile, non–spore-forming, and catalase-positive bacteria. The cell wall contains peptidoglycan and teichoic acid. The organisms are resistant to temperatures as high as 50°C, to high salt concentrations, and to drying. Colonies are usually large (6-8 mm in diameter), smooth, and translucent. The colonies of most strains are pigmented, ranging from cream-yellow to orange.
The ability to clot plasma continues to be the most widely used and generally accepted criterion for the identification of Staphylococcus aureus. One such factor, bound coagulase, also known as clumping factor, reacts with fibrinogen to cause organisms to aggregate. Another factor, extracellular staphylocoagulase, reacts with prothrombin to form staphylothrombin, which can convert fibrinogen to fibrin. Approximately 97% of human S aureus isolates possess both of these forms of coagulase.
S aureus is ubiquitous and may be a part of human flora found in the axillae, the inguinal and perineal areas, and the anterior nares. In 2001, von Eiff et al described 3 patterns of carriage: those who always carry a strain, those who carry the organism intermittently with changing strains, and a minority of people who never carry S aureus.1 Persistent carriage is more common in children than in adults.
Wenzel and Perl (1995) found that, among healthy adults, carrier rates of 11-32% were detected in the general population, and a prevalence of 25% was detected in hospital personnel.2 Using pulsed-field gel electrophoresis (PFGE) for molecular typing, von Eiff et al (2001) found that, in most patients with S aureus bacteremia, the isolate from the patient's blood is identical to that found in the anterior nares.1 Curiously, community-associated methicillin-resistant S aureus (CA-MRSA) is rarely found in the anterior nares; rather, it colonizes the skin, particularly in the perineal area. It may also colonize the pharynx, gut, and vagina.
Pathophysiology
The organism may cause disease through tissue invasion and toxin production. The toxins liberated by the organism may have effects at sites distant from the focus of infection or colonization.
Tissue invasion
The postulated sequence of events that leads to infection is initiated with carriage of the organism. The organism is then disseminated via hand carriage to body sites where infection may occur (either through overt breaks in dermal surfaces, such as vascular catheterization or operative incisions, or through less evident breakdown in barrier function, such as eczema or shaving-associated microtrauma).
The hallmark of staphylococcal infection is the abscess, which consists of a fibrin wall surrounded by inflamed tissues enclosing a central core of pus containing organisms and leukocytes. From this focus of infection, the organisms may be disseminated hematogenously, even from the smallest abscess. The ability to elaborate proteolytic enzymes facilitates the process. This may result in pneumonia, bone and joint infection, and infection of the heart valves. In immunocompromised hosts (eg, patients with cancer who are neutropenic and have a central venous line), 20-30% develop serious complications or fatal sepsis following catheter-related S aureus bacteremia.
Persistent deep-seated infections have now been linked to small-colony variants of the organism. This population is more resistant to antibiotics and grows slowly. These organisms have been described in patients with cystic fibrosis and may contribute to the persistence of S aureus in these patients.
The organism may also elaborate toxins that can cause specific diseases or syndromes. Enterotoxin-producing strains of S aureus cause one of the most common food-borne illnesses. The most common presentation is acute onset of vomiting and watery diarrhea 2-6 hours after ingestion. The symptoms are usually self-limited. The cause is the proliferation of toxin-producing organisms in uncooked or partially cooked food that an individual carrying the staphylococci has contaminated.
A rare but well-described disorder in neonates and young children is staphylococcal scalded skin syndrome (Ritter disease). The organism produces an exfoliative toxin produced by strains belonging to phage group II. Initial features include fever, erythema, and blisters, which eventually rupture and leave a red base. Gentle shearing forces on intact skin cause the upper epidermis to slip at a plane of cleavage in the skin, which is known as the Nikolsky sign. How the exfoliative toxins produce epidermal splitting has not been fully elucidated.
The most feared manifestation of S aureus toxin production is toxic shock syndrome (TSS). Although first described in children, it was most frequently associated with women using tampons during menstruation. Since the early 1990s, at least half of the cases have not been associated with menstruation. The syndrome is associated with strains that produce the exotoxin TSST-1, but strains that produce enterotoxins B and C may cause 50% of cases of nonmenstrual TSS. These toxins are superantigens, T-cell mitogens that bind directly to invariant regions of major histocompatibility complex class II molecules, causing an expansion of clonal T cells, followed by a massive release of cytokines. This cytokine release mediates the TSS; the resultant pathophysiology mimics that of endotoxic shock.
In a recent worldwide trend, the proportion of infections caused by CA-MRSA has increased. Initially noted in tertiary care centers, these infections are now increasingly common in the community. Resistance to methicillin confers resistance to all penicillinase-resistant penicillins and cephalosporins. This high level of resistance requires the mec gene that encodes penicillin-binding protein 2a. This protein has decreased binding affinity for most penicillins and cephalosporins. Methicillin resistance has a wide variety of phenotypic expression. Heterogeneous resistance, recognized in the first clinical isolates described, is the typical phenotype. In this case, all cells carry the genetic markers of resistance but only a small fraction of them express the phenotype. Less frequent is homogenous resistance, with a single population of cells that are inhibited only through high concentrations of antibiotics.
Methicillin-resistant S aureus (MRSA) was initially described in hospitalized populations. University affiliation and greater number of beds were institutional risk factors. In pediatric centers, number of beds, region, and metropolitan population correlated with increased risk. Since 1996, more patients with CA-MRSA have been described. The strains isolated from these patients are different from typical nosocomial organisms in their susceptibility patterns and in their PFGE characteristics. A clonal population, designated USA-300, has become the predominant circulating organism in most communities. Many of these strains produce the Panton-Valentine leukocidin, which is associated with a tendency to produce abscesses, invasiveness, thrombogenesis, and morbidity and mortality.
More recently, S aureus that is intermediately resistant to vancomycin has been reported in 2 hospitalized patients, which suggests that full resistance to vancomycin may eventually emerge.3 Although the possibility of interspecies transfer of vancomycin-resistance genes from vancomycin-resistant Enterococcus was originally considered as the cause of this phenomenon, none of the species isolated have carried vanA, vanB, vanC1, vanC2, or vanC3 genes. Of note, the clinical isolates with intermediate resistance to vancomycin were from patients who had undergone prolonged vancomycin therapy for MRSA. Morphologically, these isolates were found to have increased extracellular material associated with the cell wall that may have been selected for during a prolonged antibiotic course.
Frequency
United States
Numbers of both community-associated and hospital-acquired infections have increased in the past 20 years. From 1990-1992, data from the National Nosocomial Infections Surveillance System for the Centers for Disease Control and Prevention (CDC) revealed that S aureus was the most common cause of nosocomial pneumonia and operative wound infections and the second most common cause of nosocomial bloodstream infections.
Frequency of antibiotic resistance: In a disturbing trend, antibiotic resistance among these isolates has increased because of antibiotic pressure. Currently, less than 5% of clinical isolates remain sensitive to penicillin. Resistance to penicillin was reported as early as 1942 and is mediated by beta-lactamase, a serine protease that hydrolyzes the lactam ring. In the 1980s, MRSA emerged as a prominent hospital-based infection; consequently, the use of vancomycin increased. A CDC survey revealed that the proportion of methicillin-resistant isolates with sensitivity only to vancomycin increased from 22.8% in 1987 to 56.2% in 1997.4
Mortality/Morbidity
Morbidity and mortality from S aureus infection widely varies depending on the clinical entity. Although mortality is low in children with scalded skin syndrome, most fatalities are associated with delay in diagnosis.
Sex
The male-to-female ratio of skeletal infections is 2:1, mostly because boys are more likely to experience traumatic events.
Clinical
History
- Skin and soft tissue (impetigo): Typically, this starts as a small area of erythema that progresses into bullae (filled with cloudy fluid) that rupture and heal with the formation of a honey-colored crust. Although group A Streptococcus was once considered the primary agent, Staphylococcus aureus has become the major pathogen since the 1980s. S aureus exclusively causes bullous impetigo, which is observed less frequently in the United States. This form of disease seems to arise from healthy-appearing skin. The bullae rupture, leaving a denuded area with a varnish-like coating.
- Scalded skin syndrome (Ritter disease): An exfoliative toxin (see Toxin-mediated disease) causes this relatively rare syndrome, which takes the form of superficial fragile blisters that burst, leaving a tender base. The patient is often febrile and, occasionally, has mucopurulent eye discharge. This diagnosis should be made carefully, because scalded skin syndrome may be mistaken for erythema multiforme or toxic epidermal necrolysis, which can be treated with corticosteroids. Misdiagnosis delays treatment and allows exfoliation to progress, and corticosteroid therapy may potentiate bacterial superinfection. Although the mortality rate is low in children with this entity, most fatalities are associated with delay in diagnosis.
- Folliculitis, furuncle, and carbuncle: These are increasingly severe staphylococcal skin infections. Folliculitis is a tender pustule that involves the hair follicle. A furuncle involves both the skin and the subcutaneous tissues in areas with hair follicles, such as the neck, axillae, and buttocks. They are actually small abscesses characterized by exuding purulent material from a single opening. A carbuncle is an aggregate of connected furuncles and has several pustular openings. Skin infections may be self-limited, but they can also disseminate hematogenously and cause life-threatening septicemia.
- Bone infections (osteomyelitis)
- Children often present with sudden onset of fever and bony tenderness or a limp. The pain may be throbbing and severe; however, presentation in neonates can be subtle. Infants may appear well except for failure to move an extremity or pain on movement. Redness or swelling indicates that infection has spread into the subperiosteal space. Rupture of a focus of osteomyelitis into joint space can result in septic arthritis. This is often observed in neonates.
- Children with vertebral osteomyelitis present with back pain, and those younger than 3 years present with refusal to walk or with a limp. Occasionally, children with vertebral osteomyelitis present with incontinence. Children with discitis tend to present with less fever and often appear less ill than children with vertebral osteomyelitis.
- Septic arthritis: Typical findings include decreased range of motion, warmth, erythema, and tenderness of the joint with constitutional symptoms and fever. Infants (in whom the hip is the most commonly involved joint) are an exception, as these signs may be absent. The child typically lies with the involved joint abducted and externally rotated. Because pain fibers are located within the joint capsule, movements that compress the head of the femur into the acetabulum (eg, changing a diaper) cause pain. A portal of infection is almost never found, and the infection is nearly always unilateral. Patients with infection of the sacroiliac joint present with tenderness elicited during digital rectal examination and with pain during flexion, abduction, and external rotation of the hip.
- Endocarditis: The initial presentation of patients with S aureus endocarditis is fever and malaise. However, the disease has a more rapid onset than that caused by less virulent pathogens. Notably, on initial presentation, the usual physical stigmata are absent. Endocarditis may also involve healthy valves. For more detail, please see Endocarditis, Bacterial.
- Toxic shock syndrome (TSS)
- Staphylococcal TSS is a potentially life-threatening systemic bacterial intoxication. Case definition includes fever, diffuse macular erythema, and hypotension, with involvement of 3 or more of the following organ systems:
- GI - Emesis or diarrhea appears at the time of illness. Diarrhea is secretory and profuse, and is found in almost all patients with TSS but is uncommon in patients in septic shock.
- Muscular - Severe myalgia or elevated creatine kinase (CK) levels are observed. Myalgia may be one of the earliest manifestations of the disease.
- Renal - Elevation of BUN or creatinine levels or more than 5 WBCs per high-power field in the absence of a urinary tract infection is observed.
- Hepatic levels of bilirubin, serum glutamic-oxaloacetic transaminase (aspartate aminotransferase), and serum glutamic-pyruvic transaminase (alanine aminotransferase) are twice the upper limit of the reference range.
- Hematologic – The platelet count is less than 100,000/ μ L.
- Nervous system – Features include disorientation and alteration in consciousness with the absence of focal neurologic signs when fever and hypotension are absent.
- A probable case of TSS involves 5 of the above 6 findings.
- A confirmed case of TSS involves all 6 findings.
- The most striking aspect of the disease is the rapidity with which it can progress in a previously healthy individual of any age. This is especially true in postsurgical patients, particularly following nasal surgery, because this is an area commonly colonized with S aureus. Late-onset dermatologic findings include a red and pruritic maculopapular rash, desquamation of the fingers and toes, and telogen effluvium (see Toxic Shock Syndrome).
- Pneumonia: Cases of rapidly progressive and fatal staphylococcal pneumonia still occur, although they were much more common in the 1950s and early 1960s, when S aureus phage type 80/81 caused frequent disease in infants. Staphylococcal pneumonia most commonly occurs in infants, young children, and patients who are debilitated. This is a rapidly progressive disease. Patients with primary staphylococcal pneumonia present with a short prodrome of fever followed by rapid onset of respiratory distress, which may include tachypnea, retractions, and cyanosis. Patients may also have prominent GI tract symptoms. Staphylococcal pneumonia may also develop after influenza infection, which seems to occur preferentially among young adults (in whom mortality reaches 50%). Typically, the child seems to recover from a febrile illness only to once again develop an increasing fever and the symptoms mentioned above.
- Thrombophlebitis: Usually occurring in a hospitalized patient, thrombophlebitis is characterized by fever, pain, and, occasionally, erythema at the insertion site of an intravenous catheter. Occasionally, pus is expressed. Severe suppurative thrombophlebitis may occur in burn patients, with fewer than half of diagnoses made while the patients are alive.
- Deep tissue abscess and infection: Muscles (myositis and pyomyositis) and organs can become infected, including the parotid gland, eyes, liver, spleen, and kidneys. These infections typically cause fever with or without localizing pain.
Physical
- Skin and soft tissue (impetigo): The infection initially appears as a small area of erythema. Bullae (ie, blister-like lesions filled with cloudy fluid) appear as the disease progresses. As bullae heal, a honey-colored crust develops.
- Scalded skin syndrome (Ritter disease): Examination reveals superficial, fragile blisters that burst, leaving a tender base. Skin sloughs easily when touched, a condition termed the Nikolsky sign. Fever is often present, and mucopurulent eye discharge may be observed. As discussed above, the infection is often mistaken for erythema multiforme or toxic epidermal necrolysis. Misdiagnosis must be avoided.
- Folliculitis, furuncle, and carbuncle: Folliculitis is the appearance of a tender pustule involving a hair follicle. A furuncle is an apparent small abscess that exudes purulent material from a single opening. A carbuncle is an aggregate of furuncles with several openings.
- Bone infections (osteomyelitis): Fever, bony tenderness, or a limp indicate bone infections. Infants may appear well except for failure to move an extremity or pain on movement. Children with vertebral osteomyelitis present with back pain, and those younger than 3 years present with refusal to walk or with a limp. Occasionally, children with vertebral osteomyelitis have incontinence as a presenting symptom. Children with discitis tend to present with less fever and often appear less ill than children with vertebral osteomyelitis.
- Septic arthritis: Examination reveals warmth, erythema, and tenderness of the joint. Constitutional symptoms and fever are frequently observed. These findings may be absent in an infant. Children with infection of the sacroiliac joint present with tenderness elicited during digital rectal examination.
- Endocarditis: The clinical syndrome widely varies and may involve multiple organs. S aureus infection usually results in an acute course but may involve subacute disease. Most patients present with high fever. Chills and sweats and a new or worsened murmur may occur. Peripheral emboli such as Osler nodes, subungual hemorrhages, Janeway lesions, and Roth spots may be present. Other embolic phenomena may occur.
- TSS: TSS involves a fever of 38.9°C or higher. Hypotension occurs, either with blood pressure below the fifth percentile for age or with an orthostatic (lying to sitting) drop in diastolic blood pressure greater than or equal to 15 mm Hg. A diffuse, erythroderma-like rash is present. Conjunctival or vaginal hyperemia may be present. Patients may have altered sensorium, even when normotensive, or may be delirious, disoriented, or agitated without focal signs. Reddened lips and tongue may be observed. Later, on recovery, desquamation of hands and feet may occur; occasionally, alopecia occurs later.
- Pneumonia: Fever is present. Findings of respiratory distress include tachypnea, cyanosis, grunting, and retractions. Vomiting and abdominal distension occur. Clinical deterioration is rapid.
- Thrombophlebitis: Patients usually have a fever and, occasionally, have cutaneous involvement such as erythema, induration, or tenderness. Occasionally, pus is expressed at the insertion site of the catheter. The exit site often does not show signs of infection. Establishing infection of an intravascular device as the cause of fever in a hospitalized patient is a diagnosis of exclusion.
- Deep tissue abscess and infection: Localizing tenderness may be present, as may signs of inflammation.
Causes
- Skin and soft tissue (impetigo): Often occurring in young children, impetigo is spread within families and through close physical contact. Impetigo is more prevalent in warm, humid climates because of more opportunities for insect bites and cutaneous trauma. Impetigo may also be a complication of varicella. Diagnosis is usually made based on the characteristic appearance of the lesions. Bullous impetigo may also occur in endemic and epidemic patterns. Nursery outbreaks have been described, and some cases in infants have progressed to scalded skin syndrome or Ritter disease (described in History).
- Folliculitis, furuncle, and carbuncle: Recurrent staphylococcal skin infections develop in certain patients, such as those with impaired neutrophil function (eg, those with chronic granulomatous disease), patients with atopy and chronic eczema, and those with impaired circulation and diabetes mellitus. However, most patients with recurrent furunculosis are colonized with CA-MRSA but are otherwise healthy. Thus, an evaluation of the immune system in these individuals is seldom useful.
- Bone and joint infections (osteomyelitis): Osteomyelitis typically occurs in children prior to the age of epiphyseal closure. Osteomyelitis typically originates in the metaphysis of long bones in the region of most rapid growth. Osteomyelitis usually involves (in order of frequency) the lower end of the femur, the upper end of the tibia and humerus, and the radius. Most bone and joint infections result from hematogenous spread, but significant blunt trauma is a preceding event in approximately one third of cases. In addition, penetrating wounds, compound fractures, and orthopedic appliances may introduce microbial infection directly into bone. Notably, the male-to-female ratio of skeletal infections is 2:1, mostly because boys are more likely to experience traumatic events.
- Septic arthritis: Staphylococci are frequent etiologic agents of septic arthritis and, since the era of successful vaccination for Haemophilus influenzae, are now more predominant in younger age groups . Bacteria can enter the joint space through hematogenous spread, direct inoculation, or contiguous spread of infection. Because the synovial membrane has a high effective blood flow, a large number of bacteria may be delivered to the joint during a period of bacteremia. Inoculation can occur when a joint is punctured with a contaminated object, and many clinical studies reveal that the knee is more likely to be punctured. In the postantibiotic era, contiguous spread has been rare, with the exception of neonatal osteomyelitis.
- Endocarditis: Fortunately, S aureus endocarditis is rare in pediatric patients. It often involves adolescent intravenous drug users who do not have antecedent valvular disease. These patients usually present with right-sided disease with evidence of pulmonary disease, such as pulmonary abscesses or shifting infiltrates. In children with preexisting heart disease, endocarditis is often temporally related to cardiac surgery or catheterization. Children with prosthetic valves are particularly vulnerable because of the organism’s propensity to adhere to foreign materials. In addition, patients with indwelling vascular access devices are at risk, because infections from the skin can seed the catheter.
- TSS
- Infection with toxin-producing S aureus in the absence of protective antibody is an antecedent. Younger patients may be at increased risk because they lack the protective antibodies to the enterotoxins and other exotoxins responsible for producing this clinical syndrome. However, other factors may be involved; Jacobsen et al (1989) demonstrated in a small study that not all patients without antibody develop true TSS when infected with a toxin-producing strain of the organism.5
- Approximately 25% of all S aureus strains are toxigenic, and, at any time, roughly 4-10% of healthy individuals are colonized with these strains. In the 1980s, the disease was associated with the use of highly absorbent tampons in women during menstruation. Currently, many cases observed are nonmenstrual (eg, localized infections, surgery, infected varicella lesions, insect bites), and these now account for one third of all cases. These patients carry a higher mortality rate than those with menstrual TSS.
- Pneumonia: The primary form occurs without an extrapulmonary focus, presumably through direct inoculation to the lungs, and the secondary form results from hematogenous seeding of the lungs during endocarditis or bacteremia. Predisposing factors include infancy, chronic illness, and viral respiratory disease such as influenza. Patients with head injury and trauma who have nasopharyngeal carriage of S aureus are at increased risk of S aureus pneumonia.
- Thrombophlebitis: The causes are associated with infusion, including infected intravenous catheters and needles. The common point of entry for infection related to intravascular devices is the insertion site along the outside of the device.
- Deep tissue abscess and infection: These typically result from hematogenous seeding, although myositis or pyomyositis can result from contiguous spread of infection and endophthalmitis can follow trauma (injury or iatrogenic), for example.
The differential diagnoses of staphylococcal infections include the following:
- Impetigo - None
- Bullous impetigo
- Pemphigus
- Pemphigoid
- Burn
- Stevens-Johnson syndrome
- Dermatitis herpetiformis
- Scalded skin syndrome (Ritter disease)
- Nonaccidental injury
- Scalding
- Abrasion trauma
- Sunburn
- Erythema multiforme
- Toxic epidermal necrolysis
- Bone and joint infections
- Bone infarction (in patients with sickle cell disease)
- Toxic synovitis
- Leukemia
- Septic arthritis
- Trauma
- Deep cellulitis
- Henoch-Schönlein purpura
- Slipped capital femoral epiphysis
- Legg-Calve-Perthes disease
- Leukemia
- Toxic synovitis
- Metabolic diseases affecting joints (Ochronosis)
- Endocarditis - Bacteremia
- TSS
- Staphylococcal scalded skin syndrome
- Meningococcemia
- Rubeola
- Adenoviral infections
- Dengue fever
- Severe allergic drug reactions
More on Staphylococcus Aureus Infection |
Overview: Staphylococcus Aureus Infection |
| Differential Diagnoses & Workup: Staphylococcus Aureus Infection |
| Treatment & Medication: Staphylococcus Aureus Infection |
| Follow-up: Staphylococcus Aureus Infection |
| References |
| Next Page » |
References
von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. Jan 4 2001;344(1):11-6. [Medline].
Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. Sep 1995;31(1):13-24. [Medline].
Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. Feb 18 1999;340(7):493-501. [Medline].
CDC. Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep. Jul 11 1997;46(27):626-8, 635. [Medline].
Jacobson JA, Kasworm E, Daly JA. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection. Rev Infect Dis. Jan-Feb 1989;11 Suppl 1:S8-13. [Medline].
Abrahamian FM, Moran GJ. Methicillin-resistant Staphylococcus aureus infections. N Engl J Med. Nov 15 2007;357(20):2090; author reply 2090. [Medline].
Aldin AS, Kinzl L, Eisele R. [Severe complications of Staphylococcus aureus infection in the child]. Unfallchirurg. Jan 2001;104(1):85-90. [Medline].
American Academy of Pediatrics. Toxic shock syndrome. In: Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2006:660-5.
Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. Sep 2007;28(9):1047-53. [Medline].
Awad SS, Elhabash SI, Lee L, Farrow B, Berger DH. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. Am J Surg. Nov 2007;194(5):606-10. [Medline].
Baartmans MG, Maas MH, Dokter J. Neonate with staphylococcal scalded skin syndrome. Arch Dis Child Fetal Neonatal Ed. Jan 2006;91(1):F25. [Medline].
Barry W, Hudgins L, Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA. Jun 24 1992;267(24):3315-6. [Medline].
Bhalla A, Aron DC, Donskey CJ. Staphylococcus aureus intestinal colonization is associated with increased frequency of S. aureus on skin of hospitalized patients. BMC Infect Dis. 2007;7:105. [Medline].
Brinsley-Rainisch KJ, Cochran RL, Pearson ML. Dermatologists' perceptions and practices related to community-associated methicillin-resistant Staphylococcus aureus infections. Am J Infect Control. Nov 2008;36(9):668-71. [Medline].
Browne LP, Mason EO, Kaplan SL, Cassady CI, Krishnamurthy R, Guillerman RP. Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol. Aug 2008;38(8):841-7. [Medline].
Campbell W, Hendrix E, Schwalbe R, Fattom A, Edelman R. Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia. Crit Care Med. Apr 1999;27(4):798-801. [Medline].
Casas I, Sopena N, Esteve M, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus carriage at hospital admission. Infect Control Hosp Epidemiol. Nov 2007;28(11):1314-7. [Medline].
CDC. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns--Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep. Mar 31 2006;55(12):329-32. [Medline].
CDC. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 1997-1999. JAMA. Sep 22-29 1999;282(12):1123-5. [Medline].
CDC. Outbreak of staphylococcal food poisoning associated with precooked ham--Florida, 1997. MMWR Morb Mortal Wkly Rep. Dec 19 1997;46(50):1189-91. [Medline].
Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis. Feb 2008;8(2):101-13. [Medline].
Datta F, Erb T, Heininger U, et al. A multicenter, cross-sectional study on the prevalence and risk factors for nasal colonization with Staphylococcus aureus in patients admitted to children's hospitals in Switzerland. Clin Infect Dis. Oct 1 2008;47(7):923-6. [Medline].
Daum RS. Removing the golden coat of Staphylococcus aureus. N Engl J Med. Jul 3 2008;359(1):85-7. [Medline].
David MD, Kearns AM, Gossain S, Ganner M, Holmes A. Community-associated meticillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect. Nov 2006;64(3):244-50. [Medline].
Dohin B, Gillet Y, Kohler R, et al. Pediatric Bone and Joint Infections Caused by Panton-Valentine Leukocidin-Positive Staphylococcus aureus. Pediatr Infect Dis J. Nov 2007;26(11):1042-1048. [Medline].
Faden H. Mastitis in children from birth to 17 years. Pediatr Infect Dis J. Dec 2005;24(12):1113. [Medline].
Faden H, Rose R, Lesse A, Hollands C, Dryja D, Glick PL. Clinical and molecular characteristics of staphylococcal skin abscesses in children. J Pediatr. Dec 2007;151(6):700-3. [Medline].
Falagas ME, Siempos II, Vardakas KZ. Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. Lancet Infect Dis. Jan 2008;8(1):53-66. [Medline].
Farrell AM. Staphylococcal scalded-skin syndrome. Lancet. Sep 11 1999;354(9182):880-1. [Medline].
Feigen RD, Cherry JD. Coagulase positive staphylococcal infections. In: Feigen RD, Cherry JD, eds. Textbook of Pediatric Infectious Disease. Philadelphia, Pa: WB Saunders Co; 1998:Chapters 32,64,85.
Fergie J, Purcell K. The Treatment of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections. Pediatr Infect Dis J. Jan 2008;27(1):67-68. [Medline].
Fernandez M, Carrol CL, Baker CJ. Discitis and vertebral osteomyelitis in children: an 18-year review. Pediatrics. Jun 2000;105(6):1299-304. [Medline].
Fortunov RM, Hulten KG, Hammerman WA, Mason EO Jr, Kaplan SL. Evaluation and Treatment of Community-Acquired Staphylococcus aureus Infections in Term and Late-Preterm Previously Healthy Neonates. Pediatrics. Nov 2007;120(5):937-945. [Medline].
Frank AL. Staphylococcus aureus: a moving target. J Pediatr. Dec 2007;151(6):561-3. [Medline].
Fritz SA, Garbutt J, Elward A, Shannon W, Storch GA. Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics. Jun 2008;121(6):1090-8. [Medline].
Gafur OA, Copley LA, Hollmig ST, Browne RH, Thornton LA, Crawford SE. The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines. J Pediatr Orthop. Oct-Nov 2008;28(7):777-85. [Medline].
Gonzalez BE, Kaplan SL. Severe staphylococcal infections in children. Pediatr Ann. Oct 2008;37(10):686-93. [Medline].
Gonzalez BE, Teruya J, Mahoney DH Jr, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. May 2006;117(5):1673-9. [Medline].
Gorwitz RJ. A Review of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. Pediatr Infect Dis J. Jan 2008;27(1):1-7. [Medline].
Gorwitz RJ. Understanding the Success of Methicillin-Resistant Staphylococcus aureus Strains Causing Epidemic Disease in the Community. J Infect Dis. Jan 15 2008;197(2):179-82. [Medline].
Greene JN. Infections Related to Vascular Access Devices. Cancer Control. Oct 1996;3(5):456-464. [Medline].
Hamilton SM, Bryant AE, Carroll KC, et al. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. Clin Infect Dis. Dec 15 2007;45(12):1550-8. [Medline].
Heininger U, Datta F, Gervaix A, et al. Prevalence of nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) in children a multicenter cross-sectional study. Pediatr Infect Dis J. Jun 2007;26(6):544-6. [Medline].
Homma S, Sagawa Y, Ito M, Ohno T, Toda G. Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses. Clin Exp Immunol. Apr 2006;144(1):41-7. [Medline].
Huang YC, Ho CF, Chen CJ, Su LH, Lin TY. Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Household Contacts of Children With Community-Acquired Diseases in Taiwan. Pediatr Infect Dis J. Nov 2007;26(11):1066-1068. [Medline].
Hulten KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J. Apr 2006;25(4):349-53. [Medline].
Hussain A, Robinson G, Malkin J, Duthie M, Kearns A, Perera N. Purpura fulminans in a child secondary to Panton-Valentine leukocidin-producing Staphylococcus aureus. J Med Microbiol. Oct 2007;56(Pt 10):1407-9. [Medline].
Jaggi P, Paule SM, Peterson LR, Tan TQ. Characteristics of Staphylococcus aureus infections, Chicago Pediatric Hospital. Emerg Infect Dis. Feb 2007;13(2):311-4. [Medline].
Jensen JU, Jensen ET, Larsen AR, et al. Control of a methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a day-care institution. J Hosp Infect. May 2006;63(1):84-92. [Medline].
Jeyaratnam D, Reid C, Kearns A, Klein J. Community associated MRSA: an alert to paediatricians. Arch Dis Child. Jun 2006;91(6):511-2. [Medline].
John Jr JF, Lindsay JA. Clones and Drones: Do Variants of Panton-Valentine Leukocidin Extend the Reach of Community-Associated Methicillin-Resistant Staphylococcus aureus?. J Infect Dis. Jan 4 2008;[Medline].
Jones RN. Key considerations in the treatment of complicated staphylococcal infections. Clin Microbiol Infect. Mar 2008;14 Suppl 2:3-9. [Medline].
Kahl B, Herrmann M, Everding AS, et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis. Apr 1998;177(4):1023-9. [Medline].
Kaplan SL. Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis. Jul 2006;17(3):113-9. [Medline].
Kapoor V, Travadi J, Braye S. Staphylococcal scalded skin syndrome in an extremely premature neonate: a case report with a brief review of literature. J Paediatr Child Health. Jun 2008;44(6):374-6. [Medline].
Khangura S, Wallace J, Kissoon N, Kodeeswaran T. Management of cellulitis in a pediatric emergency department. Pediatr Emerg Care. Nov 2007;23(11):805-11. [Medline].
Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. Dec 2007;13(12):1840-6. [Medline].
Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. Oct 17 2007;298(15):1763-71. [Medline].
Krugman. Staphylococcus Aureus. In: Katz SL, Gershon AA, Hotez PJ, eds. Krugman's Infectious Diseases of Children. 10th. St. Louis, Mo: CV Mosby; 1998:Chapter 19.
Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. Jan 15 2006;193(2):172-9. [Medline].
Ladhani S, Joannou CL. Difficulties in diagnosis and management of the staphylococcal scalded skin syndrome. Pediatr Infect Dis J. Sep 2000;19(9):819-21. [Medline].
Lamp KC, Friedrich LV, Mendez-Vigo L, Russo R. Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am J Med. Oct 2007;120(10 Suppl 1):S13-20. [Medline].
Lee TC, Carrick MM, Scott BG, Hodges JC, Pham HQ. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg. Dec 2007;194(6):809-12; discussion 812-3. [Medline].
Levine DP, Lamp KC. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am J Med. Oct 2007;120(10 Suppl 1):S28-33. [Medline].
Lipsky BA, Weigelt JA, Gupta V, Killian A, Peng MM. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol. Nov 2007;28(11):1290-8. [Medline].
Lowy FD. Staphylococcus aureus infections. N Engl J Med. Aug 20 1998;339(8):520-32. [Medline].
Mangini E, Segal-Maurer S, Burns J, et al. Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol. Nov 2007;28(11):1261-6. [Medline].
Maranan MC, Moreira B, Boyle-Vavra S, Daum RS. Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance. Infect Dis Clin North Am. Dec 1997;11(4):813-49. [Medline].
Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis. Feb 2007;13(2):236-42. [Medline].
McCaskill ML, Mason EO Jr, Kaplan SL, Hammerman W, Lamberth LB, Hulten KG. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J. Dec 2007;26(12):1122-7. [Medline].
Mertz PM, Cardenas TC, Snyder RV, Kinney MA, Davis SC, Plano LR. Staphylococcus aureus virulence factors associated with infected skin lesions: influence on the local immune response. Arch Dermatol. Oct 2007;143(10):1259-63. [Medline].
Moumile K, Cadilhac C, Lina G. Severe osteoarticular infection associated with Panton-Valentine leukocidin-producing Staphylococcus aureus. Diagn Microbiol Infect Dis. Sep 2006;56(1):95-7. [Medline].
Murray PR, Baron EJ, Pfaller FC. Micrococci and Staphylococci. In: Murray PR, Baron EJ, Pfaller MA, Tenover TC, Yolken RH, eds. Manual of Clinical Microbiology. 7th ed. ASM Press:264-272.
Noskin GA, Rubin RJ, Schentag JJ, et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis. Nov 1 2007;45(9):1132-40. [Medline].
O'Hara FP, Guex N, Word JM, Miller LA, Becker JA, Walsh SL. A Geographic Variant of the Staphylococcus aureus Panton-Valentine Leukocidin Toxin and the Origin of Community-Associated Methicillin-Resistant S. aureus USA300. J Infect Dis. Jan 15 2008;197(2):187-194. [Medline].
Park JY, Jin JS, Kang HY, et al. A comparison of adult and pediatric methicillin-resistant Staphylococcus aureus isolates collected from patients at a university hospital in Korea. J Microbiol. Oct 2007;45(5):447-52. [Medline].
Proctor RA. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. Feb 15 2008;46(4):584-93. [Medline].
Rim JY, Bacon AE 3rd. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus colonization in a random sample of healthy individuals. Infect Control Hosp Epidemiol. Sep 2007;28(9):1044-6. [Medline].
Rochon-Edouard S, Pestel-Caron M, Lemeland JF, Caron F. In vitro synergistic effects of double and triple combinations of beta- lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. Nov 2000;44(11):3055-60. [Medline]. [Full Text].
Ruebner R, Keren R, Coffin S, Chu J, Horn D, Zaoutis TE. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics. Apr 2006;117(4):1210-5. [Medline].
Saavedra-Lozano J, Mejias A, Ahmad N, et al. Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections. J Pediatr Orthop. Jul-Aug 2008;28(5):569-75. [Medline].
Sahu DN, Thomson S, Salam A, Morton G, Hodgkins P. Neonatal methicillin resistant Staphylococcus aureus conjunctivitis. Br J Ophthalmol. Jun 2006;90(6):794-5. [Medline].
Sakoulas G, Golan Y, Lamp KC, Friedrich LV, Russo R. Daptomycin in the treatment of bacteremia. Am J Med. Oct 2007;120(10 Suppl 1):S21-7. [Medline].
Seybold U, Halvosa JS, White N, Voris V, Ray SM, Blumberg HM. Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries. Pediatrics. Nov 2008;122(5):1039-46. [Medline].
Stacey DH, Fox BC, Poore SO, Bentz ML, Gutowski KA. Community-acquired methicillin-resistant staphylococcus aureus: diagnosis and treatment update for plastic surgeons. Plast Reconstr Surg. Oct 2008;122(4):120e-7e. [Medline].
Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. Jan 15 2007;195(2):202-11. [Medline].
Tacconelli E, Cataldo MA. Antimicrobial therapy of Staphylococcus aureus bloodstream infection. Expert Opin Pharmacother. Oct 2007;8(15):2505-18. [Medline].
Tolan RW Jr. Toxic shock syndrome complicating influenza A in a child: case report and review. Clin Infect Dis. Jul 1993;17(1):43-5. [Medline].
Tolan RW Jr. Community-associated methicillin-resistant Staphylococcus aureus: overview of our current understanding. US Infectious Disease 2007 [serial online]. November 2007;II:52-4. Available from: Touch Briefings, PLC. Accessed March 26, 2008. Available at http://www.touchbriefings.com/cdps/cditem.cfm?nid=2930&cid=5.
Velissariou IM. Linezolid in children: recent patents and advances. Recent Patents Anti-Infect Drug Disc. Jan 2007;2(1):73-7. [Medline].
Viallon A, Marjollet O, Berthelot P, et al. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED. Am J Emerg Med. Oct 2007;25(8):880-6. [Medline].
Wendt C, Schinke S, Wurttemberger M, et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol. Sep 2007;28(9):1036-43. [Medline].
West SK, Plantenga MS, Strausbaugh LJ,. Use of decolonization to prevent staphylococcal infections in various healthcare settings: results of an Emerging Infections Network survey. Infect Control Hosp Epidemiol. Sep 2007;28(9):1111-3. [Medline].
Wilson AP, Hayman S, Whitehouse T, et al. Importance of the environment for patient acquisition of methicillin-resistant Staphylococcus aureus in the intensive care unit: a baseline study. Crit Care Med. Oct 2007;35(10):2275-9. [Medline].
Zaoutis TE, Toltzis P, Chu J, et al. Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatr Infect Dis J. Apr 2006;25(4):343-8. [Medline].
Zhang K, McClure JA, Elsayed S, Tan J, Conly JM. Coexistence of Panton-Valentine Leukocidin-Positive and -Negative Community-Associated Methicillin-Resistant Staphylococcus aureus USA400 Sibling Strains in a Large Canadian Health-Care Region. J Infect Dis. Jan 15 2008;197(2):195-204. [Medline].
Zingg W, Posfay-Barbe KM, Pittet D. Healthcare-associated infections in neonates. Curr Opin Infect Dis. Jun 2008;21(3):228-34. [Medline].
Further Reading
Keywords
Staphylococcus aureus, abscess, bacteremia, carbuncle, cellulitis, community-acquired methicillin-resistant S aureus, community-associated methicillin-resistant S aureus, CA-MRSA, conjunctivitis, empyema, endocarditis, folliculitis, furuncle, impetigo, methicillin-resistant S aureus, MRSA, methicillin-sensitive S aureus, MSSA, osteomyelitis, pneumonia, Ritter disease, scalded skin syndrome, septic arthritis, S aureus, Staphylococcus aureus infection, thrombophlebitis, toxic shock syndrome, TSS, staphylococcal toxic shock syndrome, wound infection
Overview: Staphylococcus Aureus Infection